Strategic Partnering Models

The perfect scale for your total success

Regardless of whether you routinely outsource or not, time and cost challenges are part of any drug discovery pipeline.

Drug discovery isn't just another outsourcing business for Crown Biosciences--it's a source of new technology and predictive strategies that may speed drugs to market. As a dedicated outsourcing company, we strongly believe in the value of creating customized solutions to meet specific needs. Crown Bio’s business model is unique to the industry as we:

  • Focusing on pre-clinical biology services
  • Accelerate R&D in a timely and cost-effective fashion
  • No internal product development pipeline
    • Data neutrality
    • No conflict of interest

Roll the mouse over the following image to discover the engagement options at Crown Bio which guarantee cost effective entry options within each of our offerings along our drug development pipeline process:

It seams that a proper Flash player is missing. The next links replaces the original Flash links : Project based model, FTE based model , Program based model, Strategic Alliance model


Contact us